David E. Flitman is Director at Avery Dennison Corp (AVY). SEC records also connect Flitman to US Foods Holding Corp. (USFD). Flitman has reported 7 insider filings with the SEC since 2025. The most recent filing was in May 2026.
Every role David E. Flitman has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Updated Aug 31, 2026
David E. Flitman is Chair of the Board and Chief Executive Officer, Director of US Foods Holding Corp. (USFD). 9 SEC Form 4 filings on record going back to 2025, most recently on 17 August 2026.
Every recent SEC Form 4 transaction David E. Flitman has reported, most recent first.
InsiderAlpha's records for David E. Flitman go back to 2025: 9 primary Form 4 filings, an average of 4.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies David E. Flitman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
David E. Flitman is a corporate insider, tracked as Chair of the Board and Chief Executive Officer, Director of US Foods Holding Corp. (USFD). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
29.0K shares @ $0.00-